Go to navigation
Go to content
Astrazeneca Worldwide
AstraZeneca Websites
Search
Main navigation
Home
Therapy Areas
Oncology/Infection
Cardiovascular
Gastrointestinal
Neuroscience
Respiratory/Inflammation
Drug Products
All Drug Products
Diseases & Conditions
All Diseases and Conditions
Glossary
Contact Us
Disclosure Commitment
You are here
Home
Total number of clinical trials
A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
Disease
asthma
Drug Name
Symbicort
Generic Name
budesonide/formoterol
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jul 4, 2007
Study Name
D5890C00017
Study Id
D5890C00017
Recruiting Status
Open
Protocol Status
Not Available
Report
Aug 12, 2011
D5890C00017.pdf
(117 KB)
Page tools
Print
Bookmark this page